期刊文献+

基因调控技术在骨组织工程中应用的研究进展 被引量:2

Research progress of gene regulation technology in bone tissue engineering
原文传递
导出
摘要 [目的]综述基因调控技术的最新研究进展,全面分析控释技术在骨组织工程中应用。[方法]广泛查阅近几年来国内外关于骨组织工程中基因表达调控的相关文献,并进行综述。[结果]基因调控技术能够严格调节成骨成血管因子表达,可以有效的避免生长因子过度表达,而导致有害的异位骨化或异常骨的形成以及异常血管或肿瘤血管的形成。[结论]生理状态下骨修复重建是多种生长因子在细胞内序贯表达,通过不同基因调控技术模拟生理状态下成血管和成骨因子序贯释放,将为研究血管化组织工程骨提供新策略。 [Objective]To review the latest research progress of gene regulation technology,and to thoroughly analyze its application in bone tissue engineering.[Method]Domestic and international literature on gene expression regulation in recent years was extensively reviewed and analyzed. [Result]The gene regulation technology could strictly regulate gene expression and effectively avoid over- expression of the bioactive factors that lead to the formation of ectopic bone or abnormal bone,as well as the development of hemangioma or abnormal blood vessels. [Conclusion]The physiological state of bone repair and reconstruction need a variety of growth factors sequential expression,through gene regulation technology to simulate this pattern to release. It will offer a new strategy for constructing vascularized bone tissue engineering.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2014年第20期1861-1867,共7页 Orthopedic Journal of China
关键词 骨组织工程 基因调控技术 骨缺损修复 bone tissue engineering gene regulation technology bone defect repair
  • 相关文献

参考文献35

  • 1Young S, Patel ZS, Kretlow JD, et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein - 2 on bone regeneration in a rat critical - size defect model[ J]. Tissue Eng Part A,2009,9:2347 - 2362.
  • 2Brown KV, Li B, Guda T, et al. Improving bone formation in a rat fe- mur segmental defect by controlling bone morphogenetic protein - 2 release [ J ]. Tissue Eng Part A, 2011,13 - 14 : 1735 - 1746.
  • 3Ramazanoglu M, Lutz R, Rusche P,et al. Bone response to biomimet- ic implants delivering BMP -2 and VEGF:an immunohistochemical study [ J ]. J Craniomaxillofac Surg,2013,8 : 826 - 835.
  • 4Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline - responsive promoters [ J ]. Proc Natl Acad Sci USA, 1992,12:5547 - 5551.
  • 5Bornkamm GW, Berens C, Kuklik - Roos C, et al. Stringent doxycyc- line - dependent control of gene activities using an episomal one - vector system[ J]. Nucleic Acids Res,2005,16 : 137.
  • 6Deuschle U, Meyer WK, Thiesen HJ. Tetracycline - reversible silen- cing of eukaryotic promoters [ J]. Mol Cell Biol, 1995,4:1907 - 1914.
  • 7Hasan MT, Schonig K, Berger S, et al. Long - term, noninvasive ima- ging of regulated gene expression in living mice [ J 1. Genesis, 2001, 3:116 -122.
  • 8Peng H, Usas A, Gearhart B, et al. Development of a self - inactiva- ting tet - on retruviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation [ J ]. Mol Ther, 2004,6 : 885 - 894.
  • 9Wang X, Cui F, Nadhu V,et al. Combined VEGF and LNP - 1 deliv- ery enhances osteoprogenitor cell differentiation and ectopic bone for- mation [ J ]. Growth Factors,2011,1 : 36 - 48.
  • 10Amara JF, Clackson T, Rivera VM, et al. A versatile synthetic dimeri- zer for the regulation of protein - protein interactions [ J ]. Proe Natl Aead Sei USA, 1997,20 : 10618 - 10623.

同被引文献31

  • 1Urist MR. Bone: formation by autoinduction. Science,1965,150(3698): 893-899.
  • 2Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblastdifferentiation and bone formation. Int J Biol Scu 2012, 8(2): 272-288.
  • 3Jin L, Li X. Growth differentiation factor 5 regulation in boneregeneration. Curr Pharm Des, 2013,19(19): 3364-3373.
  • 4Mulloy B, Rider CC. The bone morphogenetic proteins and theirantagonists. Vitam Horm, 2015,99: 63-90.
  • 5Fan J, Im CS, Guo M, et al. Enhanced osteogenesis of adipose-derived stem cells by regulating bone morphogenetic proteinsignaling antagonists and agonists. Stem Cells Transl Med, 2016,5(4):539-551.
  • 6Venkatesan J, Bhatnagar 1,Manivasagan P, et al. Alginate compositesfor bone tissue engineering: a review. Int} Biol MacromoU 2015, 72:269-281.
  • 7Chen G, Dong C, Yang L, et al 3D scaffolds with different stiffnessbut the same microstructure for bone tissue engineering. ACS ApplMater Interfaces, 2015,7(29): 15790-15802.
  • 8Hernigou P. Bone transplantation and tissue engineering. Part II:bone graft and osteogenesis in the seventeenth, eighteenth andnineteenth centuries (Duhamel, Haller, Oilier and MacEwen). IntOrthop, 2015,39(1): 193-204.
  • 9Lu CH, Chang YH, Lin SY, et al. Recent progresses in gene delivery-based bone tissue engineering. Biotechnol Advy 2013,31(8): 1695-1706.
  • 10Lei Q, Chen J, Huang W, et al. Proteomic analysis of the effectof extracellular calcium ions on human mesenchymal stem cells:Implications for bone tissue engineering. Chem Biol Interact, 2015,233:139-146.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部